Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Kingworld Medicines Group Ltd
1110Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series, Lifeline Care product serices, and Mentholatum product series brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceutical, healthcare, general foodstuffs, and medical products. In addition, the company is involved in the distribution and sale of artwork; organization of art exhibition; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities. It serves in the People's Republic of China, Japan, the United States, Canada, Hong Kong, Taiwan, Thailand, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China. Address: Majialong Chuangxin Building, Shenzhen, China, 518016
Analytics
Zielpreis von Wall Street
14.08 HKDKGV
7.75Dividendenrendite
7.31 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 1110
Dividenden-Analyse 1110
Dividendenwachstum über 5 Jahre
-28 %Kontinuierliches Wachstum
2 JahreAusschüttungsquote 5-Jahres-Durchschnitt
55 %Verlauf der Dividende 1110
Bewertung der Aktie 1110
Finanzen 1110
Ergebnisse | 2019 | Dynamik |